Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Funding Fonds Wetenschappelijk Onderzoek, 1804518N, 1800614N
Randomised, double-blind, placebo-controlled dose-escalation studies show that CJC-1295 produces sustained, dose-dependent increases in growth hormone and IGF-1, lasting several days after subcutaneous administration.[18] Ipamorelin has published human pharmacokinetic and pharmacodynamic data,[19] and has undergone a randomised phase-II study for postoperative ileus after bowel surgery.[20] But endocrine activity is not a dermatological outcome
Bakker J, Lin X and Nelson WG
This phenomenon can also be understood within the broader framework of the pharmaceuticalization of society, a process in which health and social problems are increasingly addressed through pharmaceutical solutions [16]
US$ 22.34
US$ 19.99
US$ 25.48
US$ 24.09
